Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 100,000 2.700% | -69,162 (-40.89%) | Filing |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 169,162 5.200% | 3,400 (+2.05%) | Filing |